KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessShares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

AbbVie (ABBV) Other Gross PP&E Adjustments (2016 - 2024)

Historic Other Gross PP&E Adjustments for AbbVie (ABBV) over the last 12 years, with Q4 2024 value amounting to $11.5 billion.

  • AbbVie's Other Gross PP&E Adjustments rose 599.58% to $11.5 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $11.5 billion, marking a year-over-year increase of 599.58%. This contributed to the annual value of $11.5 billion for FY2024, which is 599.58% up from last year.
  • Latest data reveals that AbbVie reported Other Gross PP&E Adjustments of $11.5 billion as of Q4 2024, which was up 599.58% from $10.9 billion recorded in Q4 2023.
  • In the past 5 years, AbbVie's Other Gross PP&E Adjustments ranged from a high of $11.5 billion in Q4 2024 and a low of $10.0 billion during Q4 2020
  • Its 5-year average for Other Gross PP&E Adjustments is $10.5 billion, with a median of $10.2 billion in 2022.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first skyrocketed by 2702.7% in 2020, then rose by 1.0% in 2021.
  • AbbVie's Other Gross PP&E Adjustments (Quarter) stood at $10.0 billion in 2020, then rose by 0.01% to $10.0 billion in 2021, then increased by 2.85% to $10.2 billion in 2022, then grew by 6.26% to $10.9 billion in 2023, then rose by 6.0% to $11.5 billion in 2024.
  • Its last three reported values are $11.5 billion in Q4 2024, $10.9 billion for Q4 2023, and $10.2 billion during Q4 2022.